Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study
Online Appendices
Files in this Data Supplement:
Appendix 1: List of the provincial databases and ethics approvals for each site
Appendix 2: ICD-9 and ICD-10 codes used to define covariates and secondary outcomes, and drug identification numbers used to define direct oral anticoagulants used in the study
Appendix 3: Supplemental material
Reviewer comments
Original submission
STROBE statement